Metabolism in Cancer Stem Cells: Targets for Clinical Treatment

Cells. 2022 Nov 26;11(23):3790. doi: 10.3390/cells11233790.

Abstract

Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming refers to the metabolic changes that occur when tumor cells provide sufficient energy and nutrients for themselves. Metabolic reprogramming plays an important role in regulating the growth and activity of cancer cells and cancer stem cells. In addition, the immune cells or stromal cells in the tumor microenvironment (TME) will change due to the metabolic reprogramming of cancer cells. Summarizing the characteristics and molecular mechanisms of metabolic reprogramming of cancer stem cells will provide new ideas for the comprehensive treatment of malignant tumors. In this review, we summarized the changes of the main metabolic pathways in cancer cells and cancer stem cells.

Keywords: ALDH1; cancer stem cell; ferroptosis; metabolism; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasms* / metabolism
  • Neoplastic Stem Cells* / pathology
  • Stromal Cells / metabolism
  • Tumor Microenvironment